Test Code: CBF

BRAF Mutation Screening, 5 Somatic Mutations

Test Methodology:

This test is for the detection of five somatic mutations found in the BRAF gene and provides qualitative assessment of mutation status. DNA will be extracted from formalin fixed paraffin-embedded (FFPE) tumor tissue and tested using real-time PCR. The result might aid the clinician in identifying cancer patients who may benefit from BRAF targeted therapy, such as vemurafenib.

Specimen Required:　

FFPE Tissues

Turnaround Time :　

Maximum to 5 days